<DOC>
	<DOCNO>NCT01473069</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability pharmacokinetics sequential ascend dos JTK-853 administer 14 day healthy subject also determine effect single dose ketoconazole steady-state pharmacokinetic profile JTK-853 metabolite M2 ( one cohort ) .</brief_summary>
	<brief_title>Two Week Study Evaluating Safety , Tolerability Pharmacokinetics Multiple Doses JTK-853 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Body Mass Index ( BMI ) ≥18.0 kg/m2 ≤30.0 kg/m2 2 . Nonsmokers subject stop smoke least 6 month prior Screening Visit 3 . Female subject must either surgically sterile postmenopausal 1 . History presence cardiac disease , include family history longQT syndrome unexplained sudden death 2 . Have use prescription medication , herbal product , overthecounter ( OTC ) medication ( except acetaminophen ) within four week prior Day 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>JTK-853</keyword>
	<keyword>Healthy subject</keyword>
</DOC>